AZD5672 is an orally bioavailable CCR5 antagonist for the treatment of rheumatoid arthritis. References: Cumming JG, Tucker H, Oldfield J, Fielding C, Highton A, Faull A, Wild M, Brown D, Wells S, Shaw J. Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis. Bioorg Med Chem Lett. 2012 Feb 15;22(4):1655-9. doi: 10.1016/j.bmcl.2011.12.117. Epub 2012 Jan 2. PubMed PMID: 22266038.

纯度：≥98%

CAS：780750-65-4